MedTrace Logo

Fascia Iliaca Compartment Block in Acute and Chronic Pain Management in Hip Fracture Patients

NCT02479828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2019-03-12

No results posted yet for this study

Summary

This study evaluates the effect of fascia iliaca compartment block (FICB) in the management of acute post -surgical pain in hip fracture patients and in the appearance of chronic post -surgical hip pain, by means of von Korff Graded Chronic Pain Scale -modified for hip pain in Greek.

Half of the patients will not receive fascia iliaca compartment block.

Conditions

  • Chronic Hip Pain

Interventions

DRUG

Fascia iliaca compartment block

40 ml ropivacaine 0,5% injected under fascia iliaca using ultrasound

DRUG

Ropivacaine

DEVICE

ultrasound

DRUG

Placebo

Sponsors & Collaborators

  • Asklepieion Voulas General Hospital

    lead OTHER_GOV

Principal Investigators

  • MARIA DIAKOMI · Asklepieion General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02479828 on ClinicalTrials.gov